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Background: Subtrochanteric femoral shortening osteotomy is a crucial procedure to prevent nerve injury in
total hip arthroplasty for severe developmental dysplasia of the hip. Transverse osteotomy was first applied, and
other modified methods have also been reported. Each has its own advantages and limitations, but no definitive
conclusions regarding differences in outcomes have been reached to date.
Methods: We therefore performed a comprehensive meta-analysis to compare the outcomes of different approaches.
37 studies (795 hips) were included in the final analysis. Meta-analysis, subgroup analysis and meta-regression were
performed.
Results: Meta-analysis and subgroup analysis showed no significant difference between transverse and modified
method. This is further confirmed by meta-regression. Method of osteotomy was found to be not associated with
nonunion rate (P = 0.472), as well as other post-operative outcomes including nerve palsy (P = 0.240), dislocation
(P = 0.735), revision (P = 0.653) and Harris hip score improvement (P = 0.562). In addition, western countries (P = 0.010)
and duration of follow-up more than 5 years (P = 0.014) were associated with higher revision rate.
Conclusions: Transverse osteotomy and modified osteotomy appear to be equivalent in terms of nonunion, safety
and efficacy. Transverse osteotomy may be recommended, due to its simplicity and convenience in adjusting the
anteversion angle. Well-designed and large-sample-size randomized controlled trials are expected to confirm and
update the findings of this analysis.
Keywords: Subtrochanteric femoral shortening osteotomy, Total hip arthroplasty, Developmental dysplasia of the
hip, Post-operative outcome, Meta-analysisBackground
Developmental dysplasia of the hip (DDH), formerly
defined as congenital dislocation of the hip, is one of the
most common neonatal deformities that may have
significant influence on the life quality of patient [1]. Its
incidence is estimated to be 3 to 5 per 1000 hips, which
is clouded by the absence of definitive diagnostic criteria
and the wide range of mild to severe anatomical varia-
tions that fall within the spectrum of DDH [2]. Although
several options exist including proximal femoral and* Correspondence: profdingyue@163.com
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unless otherwise stated.periacetabular osteotomies, total hip arthroplasty (THA)
remains the standard treatment in end stage DDH, pre-
dominantly Crowe type IV in Crowe classification [3] or
high dislocation DDH in Hartofilakidis classification [4],
which leads to significant pain and loss of function [5].
Severely dysplastic hips present challenging surgical
problems. The formation of a false acetabulum superior
to the true acetabulum may lead to the need of leg
lengthening, during the operation to get the center of
rotation more anatomically [3,6]. However, leg lengthen-
ing over 3–4 cm is associated with an increased risk of sci-
atic nerve injury [7]. Femoral shortening osteotomy has
become a standard approach to avoid nerve injury [8].his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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http://www.biomedcentral.com/1471-2474/15/331Compared with great trochanter osteotomy, subtrochan-
teric femoral shortening has been more commonly used,
because it has lower nonunion rate of osteotomy [9], and
preserves the proximal femoral metaphysis, and thus
allows for correction of rotation and the use of an
uncemented femoral component [10]. On the other
hand, it also provides correction of the excessive antever-
sion and lateral location of the abductor lever [10-12].
There are various techniques for subtrochanteric
femoral shortening osteotomy, in attempt to decrease
nonunion of osteotomy, which is one of the most com-
monly reported complications [6]. Transverse subtrochan-
teric femoral shortening osteotomy was first performed in
THA for DDH patients. Subtrochanteric femur was trans-
versely dissected to remove the excessive length, and the
both ends of osteotomy were connected (Figure 1a). Due
to the centrosymmetry of intersecting surface, adjustment
of the two fragments of transverse osteotomy during the
surgery is possible, when the initial alignment is not ideal
[13]. This is important for the correction of femoral ante-
version, the most common and one of the most important
anatomic abnormalities caused by DDH [6,10,14], which is
correlated with postoperative hip function [14].
However, the centrosymmetry of intersecting surface
in turn increases the rotational instability, which in com-
bination with a smaller surface contact might lead to
nonunion of the osteotomy [9]. Step-cut [15], oblique
[14], and chevron type [16] subtrochanteric femoral
shortening osteotomies, which we categorize as “modi-
fied osteotomy”, were introduced in attempt to enhance
the rotational stability of the osteotomy, and to reduce
the risk of rotational instability and non-union [17].
Compared with transverse osteotomy, the osteotomy
lines are step-cut, oblique and double-V-shaped, respect-
ively (Figure 1b-1d). So they were expected to haveFigure 1 Schematic illustration of different methods of subtrochanter
double-chevron (d) step-cut.lower nonunion rate of osteotomy. Many researchers
have published their results and opinions on this issue,
but few of them conducted a head-to-head comparison.
Moreover, single clinical trials are often underpowered
and lack generalizability [18]. Up to date, no definitive
conclusions regarding differences in outcomes have been
reached. We therefore systemically searched the litera-
tures currently available, and performed a comprehen-




We searched PubMed, Embase and Cochrane Library up
to August, 2014 for literatures which focused on subtro-
chanteric femoral shortening osteotomy for DDH and
specified the method of osteotomy and the outcomes,
using the following terms: ((((((congenital) OR develop-
mental)) AND hip) AND (((dysplasia) OR dislocation)
OR dislocations))) AND ((subtrochanteric) AND ((oste-
otomy) OR osteotomies)) (see Additional file 1). There
was no restriction to regions or languages. The com-
puter search was supplemented with manual searches of
the reference lists of all retrieved literatures. When there
were two or more reports describing the same popula-
tion, the most recent or complete version was involved.
Study eligibility and selection
The studies have to meet the following pre-determined
inclusion criteria:
1. It investigated the subtrochanteric femoral
shortening osteotomy in the surgical treatment of
DDH, and short- and long-term outcomes of the
surgery.ic femoral shortening osteotomy. (a) transverse (b) oblique (c)
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analysis.
3. It had been published or accepted for publication.
Literatures that failed to meet the inclusion criteria
were excluded. Besides, our exclusion criteria included:
1. Case report or review;
2. Not clinical studies (e.g. biomechanical);
3. Data of interest are not clear, and couldn’t be
obtained by contacting the authors;
4. Duplicated data.
Two reviewers (C. Li and M. Zhang) independently
evaluated the eligibility of involved studies. Discrepan-
cies between evaluators were resolved by discussion or
consultation with the corresponding author (Y. Ding).
Data abstraction
Study characteristics were retrieved including author, year
of publication, country, demographics of the population,
method of subtrochanteric femoral shortening osteotomy,
duration of follow-up, and union of the osteotomy sites.
Data were extracted independently and in duplicate by
both reviewers (C. Li and C. Zhang). Discrepancies be-
tween evaluators were resolved by discussion or consult-
ation with the corresponding author (Y. Ding).
Outcomes of interest
The following outcomes were used to compare trans-
verse and modified subtrochanteric osteotomy:
Primary outcomes
1. Nonunion (permanent failure of bone healing
without treatment, usually identified at 8 months
postoperatively). In consideration that delayed union
might also require a revision surgery sometimes, like
the case of nonunion, we also included delayed
union that required a revision surgery into the
category of nonunion.
2. Nerve palsy (transient or permanent, predominantly
caused by stretching, could happen to sciatic nerve,
femoral nerve, and occasionally to peroneal nerve).
Secondary outcomes
Dislocation (early or recurrent), revision (due to all
causes), leg-length discrepancy (average leg-length dis-
crepancy, and discrepancy within ideal range, which was
defined as 0-2 cm), Harris hip score (HHS) improvement
(proportion of the difference between post- and pre-
operative HHS in the post-operative HHS) and deep
infection.Statistical analysis
This meta-analysis was performed according to the
recommendations of Preferred Reporting Items for
Systematic Reviews and Meta-Analyses [19]. Raw rates
of outcome events were calculated in each study. As
the inverse variance weight in fixed-effect meta-
analysis is suboptimum when dealing with binary data
with low probability, the variances of the raw rates
were stabilized using Freeman-Tukey double-arcsine
transformation [20]. In the meantime, the double-
arcsine transformation could avoid the situation where
the rate and standard error of a certain outcome is
zero, which is not allowed for meta-analysis. All out-
comes were reported with 95% CIs. Wilson’s method
was used to calculate the 95% CI of the estimated rate to
construct the forest plot, because the asymptotic method
may produce confidence intervals that extend below zero,
especially when the rates are estimated to be low.
We estimated heterogeneity between studies with
Cochrane’s Q (reported as χ2 and P values), which is
calculated as the weighted sum of squared differences be-
tween individual study effects and the pooled effect across
studies, and the I2 statistic, which describes the percentage
of variation between studies that is due to heterogeneity
rather than chance [21]. I2 values of 25%, 50% and 75% are
taken to indicate low, moderate and high degrees of het-
erogeneity, respectively. When the I2 statistic didn’t exceed
50%, we selected the fixed effects model, which could
achieve higher statistical power than random effects
model. Otherwise, random effects model is adopted. Sen-
sitivity analysis was carried out to judge the weight of each
study. After the meta-analysis of transformed data, we
inversed the pooled estimate and its 95% CI back to pro-
portions [22]. Up to date, there is no widely accepted scor-
ing system for assessing the methodological quality of
observational studies with no control.
Potential sources of heterogeneity were explored fur-
ther by meta-regression analysis. The factors investigated
in meta-regression included method of osteotomy (by
comparing transverse and modified osteotomy), country
(by comparing western and eastern countries), mean age
(as a continuous variable, and then by dichotomizing the
studies by the median of 49 years), proportion of female
patients (as a continuous variable, and then by dichot-
omizing the studies by the median of 93%), duration of
follow-up (as a continuous variable, and then by dichot-
omizing the studies by the median of 5 years), and year
of publication (by dichotomizing the studies by the me-
dian of the year 2010). Categorical variables were taken
into meta-regression using dummy variables [23].
All analyses were performed using STATA statistical
software package (Version 13.0, StataCorp, 2013) using
the commands cii (to calculate Wilson CIs), metan
(for meta-analysis), metareg (for meta-regression) and
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P value <0.05 was considered to indicate statistical
significance (α = 0.05).
Results
Characteristics of eligible studies
37 studies (791 hips) were included in the final analysis
(Figure 2). None of them was randomized controlled
trial, case–control study or cohort study. The character-
istics of the included studies are listed in Table 1. Agree-
ment between the two reviewers was achieved.
Of the 37 studies enrolled in the meta-analysis, 10
were conducted in Europe [11,12,14,15,24-29], 6 in the
North America [7,16,30-33], 1 in Australia [34], and the
other 20 in Asia [9,13,17,35-51]. Female took the major-
ity of the patients, and 9 studies were based on female
patients exclusively.
Most researchers have used only one method of sub-
trochanteric osteotomy in their own studies, however,
with two exceptions. Erdemli et al. [35] applied step-cut
osteotomy in 3 hips, and transverse osteotomy in 22
hips. The other researcher, Dallari [14], performed step-
cut osteotomy in 14 hips, and oblique osteotomy in 19
hips. These two studies were split in meta-analysis and
meta-regression. The transverse group included 24 stud-




Pooled estimate of nonunion rate was 3.79% (95% CI
2.60%-5.20%). Heterogeneity among the studies was low
(I2 = 14.5%). Data of nonunion were further analyzed in
two subgroups (modified osteotomy and transverse osteot-
omy). Figure 3 showed the forest plot of subgroup ana-
lysis. There was no significant difference in nonunion rate
between modified group and transverse group (Table 2).Figure 2 Flowchart of the study selection process.Nerve palsy
Pooled estimate of nerve palsy rate was 2.63% (95% CI
1.60%-3.87%). Forest plot of meta-analysis was shown in
Figure 4. According to Table 2, there was so little het-
erogeneity among the studies (I2<0.1%), that subgroup
analysis was not necessary.
Secondary outcomes
Dislocation
Pooled estimate of dislocation rate was 5.88% (95% CI
4.22%-7.80%) Heterogeneity among the studies was
moderate (I2 = 36.2%). Data of dislocation were further
analyzed in subgroup analysis, and forest plot was con-
structed (Figure 5). No significant difference in disloca-
tion rate was revealed between modified group and
transverse group, and subgroup heterogeneity were not
significantly less (I2 = 38.4% for modified subgroup and
I2 = 38.5% for transverse subgroup) (Table 2).
Revision
Pooled estimate of revision rate due to all causes was
8.90% (95% CI 6.56%-11.50%). Heterogeneity among the
studies was moderate (I2 = 43.3%). Data of revision were
further analyzed in subgroups, and forest plot was con-
structed (Figure 6). As Table 2 indicated, no significant
difference in revision rate was shown between modified
group and transverse group.
Leg-length discrepancy
Only five studies provided related data on the number of
patients who achieved ideal rage of leg-length discrep-
ancy. Occurrence of discrepancy out of the ideal range
was analyzed. Pooled estimate of occurrence was 6.31%
(95% CI 2.90%-11.00%). Obvious heterogeneity existed
among the studies (I2 = 67.2%). Subgroup analysis was
carried out, revealing no significant difference between
modified group and transverse group (Table 2).
HHS improvement
Average HHS in each of the eligible studies have ele-
vated after the surgery. Heterogeneity among the studies
was high (I2 = 96.5%). However, subgroup analysis re-
vealed no significant difference between modified group
and transverse group (Table 2).
Deep infection
Pooled estimate of deep infection rate was 1.34% (95% CI
0.46%-2.67%). There was so little heterogeneity among the
studies (I2<0.1%), that subgroup analysis was not necessary
(Table 2).
Sensitivity analysis
Sensitivity analysis was carried out by excluding each
study in turn to ensure that no single study would be
Table 1 Characteristics of included studies




















Becker, 1995 USA 61 (48–72) N/A IV 7/4 Double-chevron 2.7 (0.3-6) 0 0
Reikeraas, 1996 Norway 54 (17–67) 93.8 IV 25/19 Transverse (3–7) 0 1
Yasgur, 1997 USA 42 (22–77) 77.8 IV 9/8 Transverse 3.6 (2–7) 1 0
Chareancholvanich, 1999 USA 51 (21–74) N/A N/A 15/11 Double-chevron 5.5 (2–8.5) 0 0
Zadeh, 1999 UK 49 (34–61) 71.4 I, II & IV 7/7 Transverse 2.6 (1.3-5.0) 1* N/A
Bruce, 2000 Australia 53 (26–77) N/A III & IV 6/5 Transverse 4.7 (0.5-7.2) 0 0
Ozturkmen, 2002 Turkey N/A N/A IV 7/7 Step-cut N/A 1 N/A
Sener, 2002 Turkey 43 (26–64) 95.7 III & IV 28/23 Step-cut 4.0 (0.6-7.7) 2 2
Decking, 2003 Germany 47 (19–58) 70.0 II.III & IV 12/10 Step-cut 5.1 (1.6-10) 0 1
Masonis, 2003 Canada 48.2 (21–70) 84.2 III & IV 21/19 Transverse 5.8 (2.0-11.2) 2 0
Erdemli, 2005 Turkey 44 (28–61) 100.0 IV 25/22 Step-cut in 3 hips 5 (2–10) 0 0
Transverse in 22 hips 1 0
Bernasek, 2007 USA 43 (17–67) 91.3 I.II.III & IV 23/20 Transverse 8 (5–14) 0 0
Gotze, 2007 Germany 41.7 (29–64) N/A III & IV 7/7 Transverse 1.5 0 N/A
Makita, 2007 Japan 59.6 (42–76) 100.0 IV 11/11 Step-cut 5.4 (2.5-14.1) 0 2
Park, 2007 Korea 44.8 (20–66) N/A III & IV 24/23 Transverse 4.7 (2.0-7.6) 3 0
Krych, 2009 USA N/A N/A IV 28/24 Transverse 4.8 2 0
Nagoya, 2009 Japan 55 (44–69) 94.4 IV 20/18 Transverse 8.1 (4–11.5) 0 0
Howie, 2010 UK 47.3 (26–75) N/A III & IV 35/28 Transverse 5.6 (2–14) 1 2
Reikeraas, 2010 Norway 48 (16–79) 70.8 III & IV 65/46 Transverse 13 (8–18) 2 2
Togrul, 2010 Turkey 42.3 (33–52) 85.7 III & IV 21/14 Transverse 3.4 (2.0-5.3) 0 0
Akiyama, 2011 Japan 58.9 (42–77) 90.9 III & IV 15/11 Transverse 6.3 (2.8-10.4) 3 0
Charity, 2011 UK 51 (33–75) 100.0 IV 18/15 Transverse 9.5 (4.3-14) 1 1
Dallari, 2011 Italy 52 (34–66) 76.9 IV 33/26 Step-cut in 14 hips 7.3 (2.2-15.3) 0 N/A
Oblique in 19 hips 1 N/A
Kawai, 2011 Japan 64.8 (57–73) 100 IV 19/12 Transverse 3.2 (0.5-8) 0 0
Kilicarslan, 2011 Turkey 46 (20–72) N/A III & IV 45/31 Transverse 7.2 (2.0-10.1) 5 0
Starker, 2011 Germany 44.6 83.3 IV 25/20 Step-cut N/A 0 N/A
Takao, 2011 Japan 60 92.0 IV 33/25 Step-cut 8 (5–11) 0 0
Zhong, 2011 China 45.2 (36–56) 100.0 IV 36/28 Transverse 4.4 (2.3-7.8) 0 0
Baz, 2012 Turkey 41.6 (24–56) 86.7 IV 21/15 Transverse 4.9 (3–8) 0 1
Hasegawa, 2012 Japan 58.5 (48–72) 100.0 IV 15/N/A Step-cut 10.2 (5–20) 0 1
Semenowicz, 2012 Poland 53.4 100.0 IV 10/10 Step-cut 2.3 0 0
Kilicoglu, 2013 Turkey 43 (27–60) 95.0 IV 20/16 Oblique 6.8 (3.7-10.3) 1* 0
Li WB, 2013 China N/A 100 IV 5/5 Transverse N/A 0 0
Li YW, 2013 China 54 (41–75) 83.3 IV 22/18 Double-chevron 8 (3–12) 0 0
Oe, 2013 Japa 64.9 (35–80) 96.2 IV 34/26 Transverse 5.2 (3–10) 0 0
Sun, 2013 China 47 (38–65) 63.3 IV 32/27 Transverse 4 (0.6-7) 0 1
Oinuma, 2014 Japan 61.5 (46–73) 100 IV 12/9 Transverse 3.7 (1.5-6.3) 0 0
Total / 50.0 88.1 / 791/N/A / / 27 14
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Study Revision Dislocation Deep
infection
Harris hip score Limb-length discrepancy Acceptable
discrepancy,
patients
Pre-operative Post-operative Pre-operative Post-operative
Becker, 1995 1 0 N/A N/A N/A N/A N/A N/A
Reikeraas, 1996 N/A N/A N/A 43 93 N/A N/A N/A
Yasgur, 1997 1 1 N/A N/A N/A N/A 1.5 N/A
Chareancholvanich, 1999 N/A 0 N/A N/A N/A 3.9 1.4 N/A
Zadeh, 1999 N/A N/A N/A 44 91 N/A N/A N/A
Bruce, 2000 N/A N/A 0 31 81 N/A N/A N/A
Ozturkmen, 2002 N/A N/A N/A N/A N/A N/A N/A N/A
Sener, 2002 0 0 0 36.9 95.3 N/A N/A 19
Decking, 2003 1 0 0 36 82 5.4 1.3 N/A
Masonis, 2003 3 3 0 32.5 73.6 N/A N/A N/A
Erdemli, 2005 N/A N/A 0 N/A N/A N/A N/A N/A
N/A N/A 0 N/A N/A N/A N/A N/A
Bernasek, 2007 1 4 0 42 82 N/A N/A N/A
Gotze, 2007 N/A N/A N/A 43 77 N/A N/A N/A
Makita, 2007 1 1 0 N/A N/A 4.7 1.2 7
Park, 2007 1 1 N/A 35.6 81.7 N/A N/A 21
Krych, 2009 N/A 4 N/A 43 89 N/A N/A N/A
Nagoya, 2009 2 0 0 N/A N/A N/A 1.2 N/A
Howie, 2010 7 3 1 N/A N/A N/A N/A N/A
Reikeraas, 2010 11 1 N/A N/A 87 N/A 1.0 N/A
Togrul, 2010 N/A 2 0 N/A N/A N/A 0.3 N/A
Akiyama, 2011 3 2 N/A N/A N/A 2.9 0.3 11
Charity, 2011 4 0 N/A N/A N/A N/A N/A N/A
Dallari, 2011 N/A N/A N/A N/A N/A 7.0 3.0 N/A
N/A N/A N/A N/A N/A N/A
Kawai, 2011 N/A 0 0 N/A N/A N/A N/A N/A
Kilicarslan, 2011 N/A 2 N/A N/A N/A 2.9 1.4 N/A
Starker, 2011 N/A N/A N/A N/A 90 N/A 0.8 20
Takao, 2011 1 2 N/A N/A N/A 5.1 2.8 N/A
Zhong, 2011 N/A 0 0 39 87 5.7 0.6 N/A
Baz, 2012 2 2 0 36.2 90.8 N/A N/A N/A
Hasegawa, 2012 4 3 0 56 85 3.8 1.4 N/A
Semenowicz, 2012 N/A N/A N/A 43.7 86 N/A N/A N/A
Kilicoglu, 2013 2 3 N/A 50 83 N/A 1.0 N/A
Li WB, 2013 0 0 N/A N/A N/A N/A N/A N/A
Li YW, 2013 0 0 0 30 91.9 2.5 1 18
Oe, 2013 0 3 0 N/A N/A 4.7 1.2 26
Sun, 2013 0 0 0 41.7 89.1 N/A N/A N/A
Oinuma, 2014 0 1 0 N/A N/A N/A N/A N/A
Total 45 38 1 / / / / /
N/A: not available.
*Delayed union that needs a second procedure.
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Figure 3 Forest plot of all eligible studies for nonunion rate.
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http://www.biomedcentral.com/1471-2474/15/331solely responsible for the heterogeneity of any result.
The results were almost the same as those when all
studies were involved.
Meta-regression
Univariate meta-regression analysis was carried out for
outcomes of interest to explore potential influencing fac-
tors. Method of osteotomy was found to be not associated
with nonunion rate (P = 0.472), as well as other post-
operative outcomes including nerve palsy (P = 0.240),
dislocation (P = 0.735), revision (P = 0.653) and Harris hip
score improvement (P = 0.562) (Table 3).
Results of the meta-regression on revision rate indi-
cated that western countries and longer follow-up (>5y)
are associated with higher revision rate (Table 3).
Meta-regression analysis was not performed for leg-
length discrepancy, due to limited quantity of eligible
studies. Similarly, there was only one case of deepinfection among all the involved studies, and thus meta-
regression was not performed for deep infection.
Publication bias assessment
Begg’s funnel plots and Egger’s regression asymmetry tests
were performed to investigate whether publication bias
existed (Figure 7). All outcomes were distributed symmet-
rically in funnel plots, indicating no obvious publication
bias. Egger’s regression asymmetry tests for nonunion,
nerve palsy, revision, dislocation, leg-length discrepancy
and HHS improvement showed no evidence of publication
bias (P value was 0.380, 0.186, 0.714, 0.165, 0.524 and
0.393, respectively). P value of Egger’s test for deep infec-
tion was 0.044, indicating a potential publication bias.
Discussion
This meta-analysis included 15 studies concerning modi-
fied osteotomy and 24 studies concerning transverse
Table 2 Outcomes of meta-analysis and subgroup analysis









95% CI Study heterogeneity
χ2 I2 P value
Nonunion 39 791 27 3.79% (2.60%, 5.20%) 39.25 3.2% 0.414
Modified subgroup 15 241 5 3.03% (1.29%, 5.51%) 8.29 0.0% 0.874
Transverse subgroup 24 550 22 4.14% (2.67%, 5.20%) 30.34 24.2% 0.140
Nerve palsy 33 712 14 2.63% (1.60%, 3.87%) 21.9 0.0% 0.910
Dislocation 27 641 38 5.88% (4.22%, 7.80%) 42.35 36.2% 0.030
Modified subgroup 9 163 9 5.47% (2.57%, 9.36%) 12.99 38.4% 0.112
Transverse subgroup 18 478 29 6.03% (4.14%, 8.29%) 29.28 38.5% 0.045
Revision 22 482 45 8.90% (6.56%, 11.50%) 45.57 53.9% 0.001
Modified subgroup 8 148 10 6.66% (3.31%, 11.12%) 14.04 50.1% 0.050
Transverse subgroup 14 334 35 9.96% (7.06%, 13.35%) 29.99 56.7% 0.005
Limb-length discrepancy 7 132* 10* 6.31% (2.90%, 11.00%) 18.37 67.3% 0.005
Modified subgroup 4 72 8 9.02% (3.64%, 16.40%) 13.86 78.4% 0.003
Transverse subgroup 3 60 2 3.72% (0.50%, 9.72%) 2.83 29.3% 0.243
HHS improvement 17 337 / 26.79% (26.35%, 27.32%) 654.87 97.6% <0.001
Modified subgroup 6 107 / 27.41% (26.52%, 28.31%) 569.55 99.1% <0.001
Transverse subgroup 11 230 / 26.61% (25.99%, 27.14%) 82.56 87.9% <0.001
Deep infection 19 393 1 1.34% (0.46%, 2.67%) 2.24 0.0% 1.000


















Figure 4 Forest plot of all eligible studies for nerve palsy rate.
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http://www.biomedcentral.com/1471-2474/15/331osteotomy. The results showed that method of osteot-
omy was not associated with nonunion rate, as well as
other post-operative outcomes including nerve palsy,
dislocation, revision, leg-length discrepancy, HHS im-
provement and deep infection. In addition, western
countries and longer follow-up (>5.1y) were associated
with higher revision rate.
According to our analysis, transverse osteotomy and
modified osteotomy didn’t show significant difference in
nonunion rate (Figure 3). The analysis also showed that
transverse and modified osteotomy didn’t show signifi-
cant difference in terms of occurrence of nerve palsy,
indicating that they have equal efficacy in preventing
post-operative complication concerning nerve stretching
(Figure 4). This could be attributed to the fact that the
occurrence of nerve palsy is predominantly associated
with the extent of leg lengthening.
In addition, occurrence of other post-operative com-
plication including dislocation and deep infection is
similar between transverse osteotomy and modified oste-
otomy. Recognized risk factors of dislocation after total
hip arthroplasty include age, sex, head diameter of
femoral prosthesis, surgical approach and experience ofsurgeon [52]. It wasn’t unexpected that method of oste-
otomy had no influence on post-operative dislocation. As
for the relationship between method of osteotomy and
infection rate, there had been different opinions. Modi-
fied osteotomies seem to take more time than trans-
verse osteotomies due to their complexity [45,46,49],
and there were several studies showing that prolonged
operation time would increase the risk of deep infection
after total hip arthroplasty [53-55]. The deduction may
seem reasonable that modified osteotomy would have
higher infection rate than transverse osteotomy. How-
ever, our meta-analysis revealed that modified osteot-
omy and transverse osteotomy shared similar infection
rate. This is probably because that the difference of
operation time for modified and transverse osteotomy
was not so significant to bring a difference in infection
rate. On the other hand, some studies suggested that
operation time might have no significant impact on
deep infection rate at all [56,57]. As for revision rate,
there’s also no significant difference. In term of clinical
improvement, modified osteotomy didn’t seem to show
better performance than transverse osteotomy in post-
operative leg-length discrepancy and HHS.
Figure 5 Forest plot of all eligible studies for dislocation rate.
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omy may not yield so good bone union as modified osteot-
omy, because of its lesser contact area for bone union, and
potential rotational instability [9,58]. However, our analysis
showed that transverse osteotomy could yield similar bone
union as modified osteotomy. In the meantime, transverse
osteotomy equally improved hip function, and is equally
safe in avoiding complications as modified osteotomy. And
modified osteotomy is reported to be under the risk of arm
fracture of osteotomy as a postoperative complication [14],
which is impossible after transverse osteotomy. We con-
cluded that transverse osteotomy share similar nonunion
rate with modified osteotomy, and is equally safe and
effective as modified osteotomy.
As a matter of fact, derotation for femoral anteversion
is usually necessary, which in turn requires prompt pre-
operative preparation and extreme accuracy of osteot-
omy to correct the femoral anteversion [13,17]. For
modified osteotomy, once dissection is performed, there
would be no chance for further adjustment of the ante-
version angle of the femoral neck. Modified osteotomy
also takes longer time than transverse osteotomy, due tothe complexity of the surgical procedure, and the tech-
nically difficult procedure needs a lot of time and exer-
cise for surgeons to master. Transverse osteotomy may
be recommended, due to its simplicity and convenience
in adjusting the anteversion angle.
Researchers have been trying to enhance the rotational
stability of osteotomy, in order to improve bone union.
Meanwhile, additional remarks should be made that
rotational stability is influenced by not only the method
of osteotomy, but also the design of implant used. Usu-
ally, DDH patient who receives THA is not so old to be
free of risk of revision, and bone cement impedes later
revision. On the other hand, possible leakage of bone
cement would disturb the bone union. Taking these into
consideration, researchers tended to perform cementless
THA for DDH patients who needed subtrochanteric fem-
oral shortening osteotomy at the same time. However,
cross section and coating of femoral prostheses vary due
to different designs. More importantly, press-fit femoral
stem used in cementless THA mainly rely on proximal
fixation, which might be insufficient to provide favorable
stability for subtrochanteric osteotomy, for subtrochanteric
Figure 6 Forest plot of all eligible studies for revision rate.
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http://www.biomedcentral.com/1471-2474/15/331osteotomy itself requires stable fixation of both prox-
imal and distal femur, on metaphysis and diaphysis,
respectively [43]. In recent years, some researchers ap-
plied modular femoral stem (e.g. S-ROM, DePuy) to
these patients [33,34,43,44,46,48], and there were few
reports on nonunion among them. Due to its distinctiveTable 3 Outcomes of meta-regression analysis
Nonunion Nerv
P Co. P
Method of osteotomy (modified vs. transverse) 0.472 −0.030 0.240
Country (western vs. eastern) 0.731 0.013 0.272
Mean Age 0.141 −0.004 0.734
Mean Age (<49y vs.≥ 49y) 0.302 0.042 0.958
Proportion of female 0.845 0.000 0.587
Proportion of female (<93% vs.≥ 93%) 0.645 0.019 0.833
Follow up 0.906 0.000 0.700
Follow up (≤5y vs.>5y) 0.937 0.003 0.871
Year of publication (2010 or before vs. after 2010) 0.187 0.051 0.244
HHS: Harris hip score; Co.: meta-regression coefficient.design, modular stem guarantees both proximal and
distal fixation, and thus has potential advantages in pro-
viding rotational stability for subtrochanteric osteot-
omy. Nevertheless, more studies are expected before
consensus is achieved whether modular stem facilitates
better union of subtrochanteric osteotomy.e palsy Revision Dislocation HHS improvement
Co. P Co. P Co. P Co.
0.051 0.653 −0.033 0.735 −0.020 0.562 −0.025
0.042 0.010 0.169 0.592 0.029 0.819 −0.010
0.000 0.760 −0.001 0.919 0.000 0.736 −0.001
−0.002 0.980 0.002 0.948 −0.004 0.940 0.004
0.000 0.721 0.001 0.367 0.003 0.290 −0.002
−0.009 0.793 0.021 0.723 0.026 0.143 0.073
0.003 0.074 0.021 0.937 0.000 0.408 −0.008
−0.006 0.014 −0.163 0.391 −0.046 0.354 0.042
0.044 0.300 0.071 0.716 0.019 0.504 0.028
Figure 7 Begg’s funnel plot of all eligible studies for (a) nonunion rate (b) nerve palsy (c) dislocation rate (d) revision rate.
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longer follow-up (>5y) are associated with higher revision
rate. Longer follow-up was to be expected on the basis of
common sense and reasonable deduction. Western coun-
tries turned out to be associated with higher revision rate,
probably due to its correlation with longer follow-up.
Mean follow-up was 8.6 years in the studies of western
countries, while 6.0 years in those of eastern countries.
This meta-analysis has the following limitations that
must be taken into account. First, all the studies in-
cluded were not randomized controlled trials, and thus
of lower level of evidence. The studies were conducted
with varying protocols and different levels of surgical
expertise. Second, we compare transverse osteotomy and
modified osteotomy, which is a category including step-
cut, oblique and double-chevron osteotomy. There were
much less studies on each of the modified osteotomy
than on transverse osteotomy, which would result in
significant loss of statistical efficacy if we compare each
to transverse osteotomy separately. On the basis that the
step-cut, oblique and double-chevron osteotomy shared
some certain common ground, we categorized them into
modified osteotomy in statistical analysis, as a strategy
against potential loss of statistical efficacy. Third, the
computer-based literature was systematic, and supple-
mented with manual searches. However, we may not be
able to identify all the relevant studies despite our pre-
cise selection. In addition, the quantity of eligible studies
was limited, and meta-regression analysis was not car-
ried out for limb-length discrepancy due to lack of data.To the best of our knowledge, this is the first meta-
analysis comparing transverse and modified subtrochan-
teric femoral shortening osteotomy in THA for DDH
patients. Second, it was conducted at an appropriate
time, when enough data have accumulated for inspection
by meta-analytical method. Third, this study was based
on systematic up-to-date searching and filtering of litera-
ture, strictly according to the predetermined inclusion
and exclusion criteria. Moreover, non-English language
studies were included to minimize publication bias
[36,44,46,48,49]. In addition, the variances of the raw rates
were stabilized using Freeman-Tukey double-arcsine trans-
formation, for the data were binary with low probability.
Last but not least, it brings out a universal conclusion by
including studies of various continents and countries.
This meta-analysis therefore provides the most up-to-
date information in this area.
Conclusions
This meta-analysis indicated that transverse osteotomy
shared similar nonunion rate with modified osteotomy,
and was equally safe and effective as modified osteotomy.
Transverse osteotomy may be recommended, due to
its simplicity and convenience in adjusting the ante-
version angle. Despite our rigorous methodology, the
inherent limitations of the included studies are barriers
for us to reach definitive conclusions. Well-designed
and large-sample-size randomized controlled trials are
expected to confirm and update the findings of this
analysis.
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